{"schema_version":"1.0","type":"article","title":"A Genetic Disease With No New Treatment for 40 Years Finally Enters a New Drug Era","url":"https://drugnews.com.tw/articles/2026-06-03-aatd-new-therapy-rna-gene-editing-en.html","markdown_url":"https://drugnews.com.tw/articles/2026-06-03-aatd-new-therapy-rna-gene-editing-en.md","lang":"en","date":"2026-06-03","publish_at":"2026-06-03T10:30:00+08:00","updated_at":"2026-06-03","category":"商業分析系列","topic":"臨床與 CMC","tags":["Clinical and CMC","Immunology","Biotech business analysis","Drug development"],"summary":"AATD is entering a new treatment cycle after decades of limited options, with RNA and gene-based approaches trying to move the field beyond symptom control and protein replacement.","key_points":[],"facts":[],"sections":["Core Thesis","Why It Matters","Reading Framework","What To Watch Next","Original Chinese Edition"],"references":[],"images":[],"cover_image":"https://drugnews.com.tw/assets/english/drugnews-english-analysis-cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-06-03）。A Genetic Disease With No New Treatment for 40 Years Finally Enters a New Drug Era。https://drugnews.com.tw/articles/2026-06-03-aatd-new-therapy-rna-gene-editing-en.html","disclaimer":"This article is intended for industry research and knowledge sharing only. It does not constitute investment, medical, fundraising, or individual stock advice.","translations":{"zh-Hant":"2026-06-03-aatd-new-therapy-rna-gene-editing.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}